ARTICLE | Management Tracks
New CFO, commercial officer at Pulmocide
Plus: Helmling named CBO at eTheRNA, and updates from EpimAb, Ring, Amarna, XNK and more
June 8, 2023 11:40 PM UTC
Respiratory disease company Pulmocide Ltd. hired Matt Dallas as CFO and Ashish Sagrolikar as chief commercial officer. Dallas was most recently CFO of Zealand Pharma A/S (CSE:ZEAL), and Sagrolikar was COO at Zogenix Inc.
mRNA therapy eTheRNA immunotherapies N.V. hired Steffen Helmling as CBO to expand the company’s portfolio of partners globally. Helmling was CBO at X-Chem Inc., a DNA encoded library technology company...